A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508 A (Levovist®) for Doppler signal enhancement in the portal vascular system - Gebel, M; Caselitz, M; Bowen-Davies, P E; Weber, S (Ultraschall in der Medizin - European Journal of Ultrasound, 1998)